Issue Date: May 7, 2007
Pharmaceutical Firms Add Transparency
Eli Lilly & Co. is launching a website to publicize all educational grant funding and other contributions it makes to U.S.-based organizations. The website will show the organizations receiving grants and how the money is being spent. The company provides money to a host of hospitals and universities doing research in disease areas, such as endocrinology, neuroscience, and oncology, in which Lilly has expertise or is developing drugs. Meanwhile, Pfizer has launched a site to list the postmarketing studies it has agreed to conduct after a drug is launched. The studies are often a requirement in FDA's approval of a drug and can be critical to understanding long-term safety.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society